ALB and cancer: Among all these nanocarriers, albumin-based lipid nanoparticles have gained much more attention in cancer therapy because they combine the biocompatibility and mucoadhesivity of lipids and endogen proteins while avoiding the immunogenicity and biological instability exhibited by most organic nanoparticles [14].